Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome

Journal of Rheumatology

Volumn 26, Issue 1, 1999, Pages 86-90

  Guglielmone, Hugo A ^a   Fernandez, Eduardo J ^b  

^a Lab Analisis Clinicos E   (Argentina)

^b NONE

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Recurrent spontaneous abortion; Thrombosis lupus anticoagulant

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PREGNANCY; THROMBOSIS;

EID: 0032917250     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Triplett DA, Brandt JT. Lupus anticoagulant: misnomer, epiphenomenom. Hematol Pathol 1988;2:121-43.
2. Zini JM. Physiopathology of thrombosis induced by antiphospholipid antibodies. Clin Rev Allergy Immunol 1995;13: 5-9.
3. Vermylen J, Arnout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes? J Lab Clin Med 1992;120:10-2.
4. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49:193-280.
5. Harris EN, Pierangeli SS. Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol 1994;16:223-45.
6. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes lipid-binding inhibitor of coagulation beta 2-glycoprotein (apoliprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
7. Boffa MC, Berard M, Sugi T, McIntyre JA. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II Kininogen reactivity. J Rheumatol 1996;23:1375-79.
8. 2-glycoprotein 1. Clin Immunol Immunopathol 1994;72:187-92.
9. Ousting JD, Derkse RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism? Blood 1993;81:2618-25.
10. Falcon CR, Hoffer AM, Forastiero RR, Carreras LO. Clinical significance of various ELISA assay for detecting antiphospholipid antibodies. Thromb Haemost 1990;64:21-5.
11. Exner T, McRea J. Studies on the relationship between "antiphospholipid" antibodies and the lupus anticoagulant. Blood Coagul Fibrinolysis 1990;1:17-21.
12. Cines DB, McCrae KR. The antiphospholipid-protein syndrome. J Clin Immunol 1995;15 Suppl 6:86S-100S.
13. Sammaritano L, Gharavi A, Lockshin M. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 1990;20:81-96.
14. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 1996;47:533-53.
15. Sohngen D, Wehmeir A, Specker C, Schneider W. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome. Semin Thromb Hemostas 1993;20:55-63.
16. Triplett DA. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995;78:1-31.
17. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996;100:530-6.
18. Melk A, Mueller-Eckherdt G, Polten B, Lattermano A, Heine O, Hoffman O. Diagnostic and prognostic significance of anticardiolipin antibodies in patients with recurrent spontaneous abortion. Am J Reprod Immunol 1995;33:228-33.
19. Gharavi AE, Harris EN, Asherson RA, Hughes GR. Anticardiolipin antibodies isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
20. Kalunian KC, Peter JC, Middlekauff HR, et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988;85:602-8.
21. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41:8-15.
22. Zarrabi MH, Zucker S, Miller F, Derman RM, Varma AO. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med 1979;91:194-9.
23. Burden AD, Tillman DM, Foley P, Holme H. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1996;35:411-5.
24. Molina JF, Gutierrez-Urena S, Molina J, et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J Rheumatol 1997;24:291-6.
25. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
26. Stirrat GM. Recurrent miscarriage. I. Definition and epidemiology. Lancet 1990;336:673-5.
27. Villa P, Aznar J, Jorquera J, Casaña P. Laboratory diagnosis of APC-resistance in patients with lupus anticoagulant. Thromb Haemost 1995;74:1606-7.
28. Martin BA, Branch DW, Rodgers GM. Sensitivity of the activated partial thromboplastin time, the diluted Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions. Blood Coagulant Fibrinolysis 1996;7:31-8.
29. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant. Blood 1986;68:869-74.
30. Triplett DA, Brandt JT, Kaczor D, Schaffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678-82.
31. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulant. Thromb Haemostas 1991;65:320-2.
32. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay: standardization and quantitation of results. Clin Exp Immunol 1985;62:738-45.
33. Reyes H, Dearing L, Shoenfeld Y, Peter JB. Antiphospholipid antibodies: a critique of their heterogeneity and hegemony. Semin Thromb Hemostas 1994;20:89-100.
34. Harris EN, Chan JK, Asherson RA, Gharavi AE, Hughes MD. Thrombosis, recurrent feta loss, thrombocytopenia: predictive values of IgG-anticardiolipin antibodies. Arch Intern Med 1989;146: 2153-6.
35. Alving BM, Barr CF, Tang DB. Correlation between lupus anticoagulant and anti-cardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Am J Med 1990;88:112-6.
36. Qamar T, Levy RA, Sammaritano L, Gharavi AE, Lockshin MD. Characteristic of high titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death. Arthritis Rheum 1990;33:501-4.
37. Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemostas 1995;74:1361-7.
38. Loizou S, Cofiner C, Weetman AP, Walport MJ. Immunoglobulins class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 1992;90:434-9.
39. Triplett D, Brandt J, Musgrave K, Orr C. Relationship between lupus anticoagulant and antibodies to phospholipid. JAMA 1988;259:550-4.
40. Lopez LR, Santos ME, Espinoza LR, LaRosa FG. Clinical significance of immunoglobulin A versus G and M anticardiolipin antibodies in patients with systemic lupus erythematosus. Am J Clin Pathol 1992;98:449-54.
41. Selva-O'Callagham A, Ordi-Ros J, Monegal-Ferran F, Martinez N, Cortes-Hernandez F, Vilardell-Tarres M. IgA anticardiolipin antibodies, relation with other antiphospholipid antibodies and clinical significance. Thromb Haemostas 1998;79:282-5.
42. Nojima J, Suehisa E, Akita N, et al. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant. BrJ Haematol 1997;96:447-50.